CD11b+ interstitial macrophages are required for ischemia‐induced lung angiogenesis

Abstract The importance of myeloid cells in promoting neovascularization has been shown in a number of pathological settings in several organs. However, the specific role of macrophages in promoting systemic angiogenesis during pulmonary ischemia is not fully determined. Our past work suggested that cells of monocytic lineage contributed to systemic angiogenesis in the lung since clodronate‐induced depletion of all macrophages resulted in attenuated neovascularization. Our current goals were to define the population of macrophages important for systemic vessel growth into the lung after the onset of pulmonary ischemia in mice. Interstitial macrophages (CD64+ MerTK + CD11b+) increased significantly as did the percent of CD45+ Ly6G+ neutrophils 1 day after the induction of left lung ischemia, despite the fact there was limited cell recruitment due to complete obstruction of the left pulmonary artery in this ischemia model. Since both interstitial macrophages and neutrophils express CD11b, we used CD11b+ DTR mice and showed the critical role for these cells since CD11b+ depleted mice showed no systemic angiogenesis 7 days after the onset of ischemia when compared to control mice. Coculture of mouse aortic endothelial cells with macrophages showed increased proliferation relative to endothelial cells in culture without inflammatory cells, or pulmonary artery endothelial cells. We conclude that CD11b+ leukocytes, trapped within the lung at the onset of ischemia, contribute to growth factor release, and are critical for new blood vessel proliferation.


Introduction
The importance of inflammatory cells in promoting neovascularization has been shown in a number of pathological settings in several organs. Specifically, macrophages have been shown to be proangiogenic and essential to the overall process of neovascularization. Functioning both in a paracrine manner by providing growth factors, as well as serving as structural components to new sprouting capillaries, recruited macrophages have been confirmed at the site of sprouting blood vessels (Bourghardt Peebo et al. 2011;Avraham-Davidi et al. 2013;Melgar-Lesmes and Edelman 2015). The role of macrophages in ischemia-induced neovascularization has not been fully determined although phenotypically different populations may be involved at different sites within an organ as well as time points in the reparative process (Hakimzadeh et al. 2016). Understanding the normal sequelae and phenotype is important from a tissue engineering perspective to optimize tissue homeostasis (Eaton et al. 2015). However, knowledge of macrophage activation critical for neovascularization in ischemic peripheral organs may not be translatable to the lung. Tissue hypoxia is a key stimulant during ischemia in peripheral organs, which does not occur in the well-oxygenated environment of the ventilated lung. Previous work from our laboratory showed that myeloid-derived cells contributed to systemic angiogenesis during pulmonary ischemia since clodronate depletion of all macrophages resulted in attenuated neovascularization (Moldobaeva et al. 2011). Macrophage-derived cytokines have also been shown to be important for blood vessel growth (Keeley et al. 2008;Hattori et al. 2013). Although several lung cell types are known to secrete growth factors that promote endothelial cell proliferation, macrophage-derived factors are prominently induced in lung angiogenesis (Srisuma et al. 2003;Keeley et al. 2008). After the onset of chronic pulmonary ischemia, the prototypic M1 macrophage cytokine IL-6 was shown to be critical for systemic angiogenesis (McClintock and Wagner 2005) as well as the CXC chemokines (S anchez et al. 2007).
Under normal homeostatic conditions in the lung, interstitial macrophages constitute a very small macrophage subpopulation compared to the more prominent alveolar macrophages. Precursor circulating blood monocytes are recruited to the lung at times of tissue injury (Wilson et al. 2009;Geissmann et al. 2010) where they can both differentiate and proliferate (Jenkins et al. 2011). Yet, it is not clear whether recruited cells are required for the recovery that occurs with ischemia after pulmonary artery obstruction. Since the mouse lacks a subcarinal bronchial vasculature (Mitzner et al. 2000), few inflammatory cells can be recruited to the lung during pulmonary artery obstruction. Thus, the early changes in macrophage phenotype reflect predominantly in situ maturation and/or proliferation.
Our previous work suggested that interstitial macrophages rather than the more abundant alveolar macrophage, were likely important for systemic neovascularization in the ischemic lung (Moldobaeva et al. 2011). Since those observations were reported, however, subsets of lung macrophages have been more extensively characterized (Eldredge et al. 2016;Gibbings et al. 2017;Mould et al. 2017;Reddy and Mehta 2017). Additionally, genetically targeting different macrophage populations in mice is available (Cailhier et al. 2005;Borthwick et al. 2016). Thus, we sought to define the macrophage population most critical for systemic endothelial growth during ischemia. Based on our observations, we sought to further compare the effects of macrophages and neutrophils on the proliferation of pulmonary endothelium versus systemic endothelial cells to better explain the overall process of angiogenesis during lung ischemia. Our work demonstrates a requirement for CD11b + leukocytes for systemic endothelial cell growth in the lung.

Methods
Mice C57BL/6 (male, 6-8 week; Jackson Labs) and CD11b DTR (bred on site) mice were housed in a pathogen-free facility. Experimental protocols were approved by The Johns Hopkins Animal Care and Use Committee (Protocol # MO13M239). Systemic angiogenesis during left lung ischemia was studied in anesthetized (2% isoflurane), ventilated (120 breaths/min, 0.2 mL/breath) mice after left pulmonary artery ligation (Mitzner et al. 2000;McClintock and Wagner 2005;Moldobaeva et al. 2011;Zhong et al. 2016). Using mice that express the human diphtheria toxin (DT) receptor under the control of the CD11b promoter (CD11b DTR mice; Cailhier et al. 2005), the essential nature of CD11b + leukocytes to the process of systemic angiogenesis was studied. In experiments using CD11b DTR mice, CD11b + leukocytes were depleted by ip injection of DT (20 ng/g body weight) 1 day before the onset of ischemia.

Angiogenesis index
Systemic neovascularization of the lung was determined by blood flow assessment 7 days after the onset of left lung ischemia by fluorescent bead (10 lm; Invitrogen) infusion (Zhong et al. 2016). Microspheres lodged in the left lung were quantified following tissue digestion and fluorescent dye extraction. This in vivo approach to the quantification of systemic angiogenesis in the lung has provided a long-term, consistent, and reproducible assessment of new vessel growth to the murine lung (Mitzner et al. 2000;McClintock and Wagner 2005;S anchez et al. 2007;Nijmeh et al. 2010;Zhong et al. 2016). Complete validation of this approach to quantify angiogenesis in the lung was previously published (Zhong et al. 2016). Data are presented as % of microspheres in the left lung relative to the total delivered (angiogenesis index).

Preparation of cell suspensions for FACS
Using a digestion protocol optimized for leukocyte recovery, left lungs were collected in dissociator tubes (Miltenyi) with Dulbecco's modified Eagle's medium (DMEM) containing Collagenase D (2 mg/mL), 40 U/mL DNase I (Roche Applied Science) and Hepes buffer (10 mmol/L). Tissues were homogenized by a Gentle-MACS dissociation machine (Miltenyi) and incubated (37°C, 30 min). Samples were passed through a 70 lm nylon strainer (BD Biosciences). Red blood cells were removed using ACK lysis buffer (Invitrogen), and cells were collected and washed thoroughly with cold PBS. Single cell suspensions were labeled in 100 lL of fluorescence-activated cell sorting (FACS) buffer containing PBS with 0.5% BSA, and incubated for 30 min on ice. The following fluorescence-conjugated anti-mouse antibodies were used: CD16/CD32, CD45, Ly6g, and ki67 (BD PharMingen), CD11b, MerTK (eBioscience), F4/80, CD11c, CD64, Ly6c, MHC II and CD31 (Biolegend). Dead cells were excluded, using VIVID (Invitrogen). For each antibody, the fluorochrome and antibody dilution are included in Table 1. Optimal concentrations were determined by antibody titration assay. The gating strategy for defining leukocyte populations is presented in Figure 1.
Gating controls were fluorescence minus one for each color and to exclude artifacts, time gating, doublets and cell debris exclusion were performed. All data were analyzed with FlowJo 9.9.6 software (Tree Star).

In vitro macrophage culture
Single-cell suspensions of left lung (2 9 10 5 cells/200 lL) were dispensed onto 96-well plates in DMEM (with 10% fetal calf serum [FCS]). The plate was incubated for 2 h (37°C in 5% CO 2 ). Nonadherent cells were discarded, and fresh media was added to the adherent fraction and incubated (37°C in 5% CO 2 ). Supernatants were collected after 24 h and used for measuring the production of MIP-2a (CXCL2) and IL-6 by ELISA (R&D systems). Cell pellets from plates were collected with tissue protein extraction reagent (T-PER; Thermo Scientific) containing protease inhibitors. Cells were homogenized and total protein measured (BCA kit; ThermoFisher).

Statistical analysis
Data are presented as the mean AE SE. Analysis of variance was used to compare multiple groups followed by Dunnett's Multiple Comparison test. Two sample comparisons were analyzed with unpaired t-tests. A log transform was performed on cytokine levels from coculture experiments due to the wide concentration range measured; P < 0.05 was accepted as significant.

Leukocyte characterization after ischemia
Experiments to assess the importance of resident inflammatory cells to the process of neovascularization after the onset of acute ischemia were performed to extend previous observations using specific leukocyte markers in isolated left lung homogenate. The complete gating strategy is presented in Figure 1.

Macrophages
Representative plots from flow cytometry of lung macrophages D1 after the onset of complete left lung ischemia are shown in Figure 2A. We focused primarily on the changes that took place by 24 h after the onset of ischemia (D1) since our previous studies showed maximum changes at this time point (Moldobaeva et al. 2011;Zhong et al. 2016). Quantification of the changes in total macrophages (% of leukocytes), alveolar and interstitial macrophages (% of macrophages) immediately after the onset of ischemia (0h) and D1 after ischemia are presented in Figure 2C (n = 4 mice/group). Within the same lung samples, macrophages labeled either as done previously (CD45 + , CD11c + , MHCII int ; Moldobaeva et al. 2011) or as CD45 + CD64 + MerTK + shown in Figure 1, demonstrated an increase in the population of lung leukocytes by D1 compared to what was present at 0h ( Fig. 2B, a). This increase was due exclusively to the increased percentage of interstitial macrophages (CD11b + ; Fig. 2B, b). When this new antibody panel of more selective surface markers was used to identify subpopulations, a significant decrease in the percentage of alveolar macrophages was apparent (CD11b À ; Fig. 2B, c). Thus, within the same mice, we confirmed our previous observations of the increase in interstitial macrophages using a separate set of surface markers currently used to define this population. In a separate series of mice (n = 3-4 mice/time point), the absolute numbers of leukocytes was determined over the early time course after ischemia. A significant decrease in the total number of cells was apparent D1 and D3 after ischemia compared to 0h (Fig. 3). Using the average absolute values as estimates of leukocyte numbers and the confirmed significant increase in the percentage of interstitial macrophages (Table 2), resulted in a 4.5-fold increase in the calculated number of interstitial macrophages while alveolar macrophages remained the same. Thus, both by percentages or total numbers, a significant increase in interstitial macrophages was seen as a result of left lung ischemia. To evaluate whether macrophage proliferation was responsible for the significant increase in interstitial (CD11b + ) macrophages at D1, the abundance of the proliferation marker ki67 was determined. Average proliferation of this cell population was 7% and this did not change D1 after the onset of ischemia (n = 5 mice/time point; P = 0.72). As seen in Figure 2C and D, further analysis of interstitial macrophages demonstrated a predominance of MHCII lo and MHCII intermediate cells at 0h and D1. Together these two groups comprised the majority, were variable, but have been shown recently to be mature macrophages important for cytokine expression (Gibbings et al. 2017).

Monocytes
Overall the percent of monocytes as a fraction of all leukocytes decreased significantly (Table 2). Yet the fraction of the more mature Ly6C +lo subtype increased D1 after the A significant increase in the percent of macrophages was observed at D1 (a), which was due exclusively to the significant increase in interstitial macrophages (b), since alveolar macrophages showed a significant decrease (c). (C) Representative contour plots of alveolar macrophages (ALV) compared to interstitial macrophages (IM), and subsequently the activation status of interstitial macrophages (Gibbings et al. 2017  onset of ischemia ( Fig. 2E and F). These results are consistent with the suggestion that trapped monocytes differentiated to a more mature phenotype (Crane et al. 2014).

Granulocytes
Neutrophils were determined by two different gating strategies in the present series and were defined by CD45 + CD64 À MerTK À F4/80 À (Gibbings et al. 2017) or by CD45 + Ly6G + (Yu et al. 2016, Fig. 1). Both methods demonstrated similar statistically significant increases in the % of neutrophils D1 after ischemia (Table 2; Fig. 2G and H). When cell numbers from the independent series (Fig. 3) were used to estimate total neutrophil numbers based on these percentages, a small increase was observed at D1 relative to 0h (1.6-fold increase). No change in eosinophils was observed (Table 2).

CD11b DTR mice
To determine the importance of the CD11b + leukocytes (macrophages, neutrophils, eosinophils) to subsequent angiogenesis, CD11b DTR mice with DT-induced depletion were studied. Figure 4 demonstrates the CD11b + depletion strategy and timeline of measurements. When this approach was applied, functional angiogenesis was essentially eliminated as shown in Figure 5. We have previously used the 14-day time point to establish an angiogenic phenotype (Moldobaeva et al. 2011;Zhong et al. 2016). However, given this DT treatment of CD11b DTR mice, a 40% mortality rate was observed thus requiring a shorter time period for the functional angiogenesis evaluation. Control responses included PBS-treated CD11b DTR mice as well as DT-treated wild-type mice as noted by the different symbols used. A significant decrease in the angiogenic index was observed in the CD11b + depleted mice (n = 4-6 mice/ group; P = 0.01). The control response after 7 days of ischemia was 0.9 AE 0.2%, which is similar to what was reported previously (Zhong et al. 2016). This result demonstrates that CD11b + leukocytes are essential to the process of systemic angiogenesis after the induction of pulmonary ischemia.

Leukocyte changes in CD11b DTR mice
To determine the population of CD11b + leukocytes critical to the angiogenic process and to confirm the effectiveness of DT treatment, D1 left lung homogenate of PBS-treated mice was compared to DT-treated mice. Average numbers of leukocyte populations are presented in Figure 6, and representative plots from flow cytometry comparing D1 PBS versus D1 DT-treated mice ( Fig. 7A and C) with average data for macrophages and neutrophils compared ( Fig. 7B and D; n = 4 mice/group). Substantial and significant reductions in CD11b + interstitial macrophages and neutrophils were seen after DT treatment.

Cytokine release by macrophages
To explore one mechanism by which CD11b + macrophages may be contributing to angiogenesis, macrophages 0.0 Figure 3. Time course of changes in total leukocyte numbers in dissociated lung. Cell count after left lung dissociation prior to staining procedures demonstrates a significant decrease in cell numbers D1 and D3 after left lung ischemia relative to immediately after the onset of ischemia (0h). n = 3-4 mice/group, mean AE SE; *P < 0.05. were collected from the lungs of PBS and DT-treated CD11b DTR mice 1 day after the onset of ischemia. Adherent cells were evaluated for their ability to secrete the prototypic M1 cytokine IL-6 and the prototypic M2 cytokine MIP-2a (CXCL2). Flow cytometric analysis of D1 cells demonstrated that at least 84% of cells recovered were F4/80 + macrophages. Figure 8 demonstrates that these macrophages derived from DT-treated CD11b DTR mice secreted significantly less MIP-2a (P = 0.005) and IL-6 (P = 0.028) than macrophages from PBS-treated CD11b DTR mice (n = 6-7 mice/group).

Endothelial cell proliferation
To examine whether macrophages and neutrophils altered endothelial cell proliferation, in vitro coculture of aortic and pulmonary artery endothelium was studied. As shown in Figure 9A, mouse systemic arterial endothelium (ma) cocultured with isolated lung macrophages (ma + mac) showed the only statistically increased level of proliferation relative to endothelium alone (n = 5 exp/group). This was true despite the fact that these were all lung macrophages without CD11b + selection. Although co-culture with interstitial macrophages was the preferred experiment, it proved technically difficult given the small population of this cell type in normal lungs. No changes in pulmonary endothelial cell proliferation were seen. The cytokines (MIP-2a and IL-6) that were decreased in isolated macrophages from DT-treated mice were evaluated in coculture supernatants. Coculture of macrophages and neutrophils both caused a significant increase in MIP-2a and IL-6, with macrophages showing on average the greatest increase in cytokines (Fig. 9B).

Discussion
Inflammatory cells are purported to play a key role in promoting systemic angiogenesis in asthma, cystic fibrosis, and supporting primary carcinomas, among several lung diseases. However, identifying which specific cells in these inflammation-associated pathologies promote neovascularization uniquely, has been difficult to discern. Although mast cells (Mukai et al. 2018   2018 | Vol. 6 | Iss. 11 | e13721 Page 9 monocyte differentiation. The number of monocytes decreased with ischemia and those measured were of a more mature Ly6c lo phenotype. When CD11b + interstitial macrophages were depleted in CD11b DTR mice, angiogenesis was essentially eliminated based on the level of systemic perfusion to the lung. Lung macrophages isolated from CD11b + -depleted CD11b DTR mice demonstrated significantly decreased secretion of IL-6 and MIP-2a compared to controls. Since these two cytokines are known to be critical for angiogenesis in this ischemia Previous results from our laboratory showed a requirement for macrophages in the lung after the onset of ischemia to promote systemic angiogenesis (Moldobaeva et al. 2011). Macrophage depletion with clodronate liposomes before left pulmonary artery obstruction, reduced systemic neovascularization of the left lung evaluated 14 days after the onset of ischemia. In this study, we used two separate antibody panels and gating strategies to define critical macrophage populations within the same mice. This approach confirmed our past observations (Moldobaeva et al. 2011) and demonstrated a refinement in macrophage phenotyping consistent with current strategies used by others in mouse models of lung disease (Eldredge et al. 2016;Gibbings et al. 2017;Mould et al. 2017;Reddy and Mehta 2017).
Pulmonary artery obstruction stopped pulmonary inflow and prevented recruitment of inflammatory cells. Furthermore, mice have no subcarinal bronchial circulation and systemic arterial inflow from intercostal arteries does not occur until approximately 5 days after the onset of ischemia (Mitzner et al. 2000). Consequently, our results emphasize the importance of in situ monocyte maturation during ischemia-induced lung injury. Landsman demonstrated that monocyte maturation in the lung to CD11b + macrophages, and subsequently to fully differentiated alveolar macrophages (CD11b À ), developed along a continuum and were stimulated by the local lung environment . With regard to pulmonary ischemia, the Fisher laboratory has shown in a series of studies, the loss of shear stress specifically results in the release of reactive oxygen species (ROS) from pulmonary endothelium (Chatterjee et al. 2008;Browning et al. 2012). In previous studies, our laboratory has confirmed an increase in ROS within the first 24 h after the onset of ischemia and its importance for subsequent systemic angiogenesis (Nijmeh et al. 2010). Whether endothelial cell-derived ROS can directly activate monocyte differentiation in this model is not clear although intracellular ROS production is required for monocyte differentiation (Zhang et al. 2013).
To fully confirm the importance of the CD11b + leukocyte to the process of systemic angiogenesis to the lung, we used CD11b DTR mice. DT treatment of CD11b DTR mice expressing the human DT receptor under the control of the CD11b promoter, have been used in a wide variety of disease models and have proved to be an effective tool in targeting specifically CD11b + leukocytes Mirza et al. 2009;Borthwick et al. 2016). Depletion of CD11b + leukocytes and confirmed at the D1 time point, had a profound influence on limiting neovascularization to the ischemic left lung. The routinely used endpoint of 14 days to measure the functional perfusion of systemic vessels into the lung in this model could not be used because of the high overall mortality rate. Forty percent of the CD11b + depleted CD11b DTR mice recovered from surgery but died prior to 14 days. Hence, to acquire the data shown in Figure 5, the earlier 7-day time point was used to measure systemic perfusion to the lung. The control level of angiogenesis was similar to what we showed previously as the angiogenic index at 7 days after ischemia in wild type mice (Zhong et al. 2016) and CD11b + leukocyte depletion significantly reduced the angiogenic index. Although CD11b + leukocytes may perform other essential systemic functions, the results are consistent with the requirement of CD11b + macrophages and possibly neutrophils to promote lung neovascularization by 7-14 days after complete left lung ischemia to preserve life. Our work is consistent with a growing body of literature showing the essential nature of CD11b + leukocytes for angiogenesis. In other systemic organs, current understanding of angiogenesis shows that recruited CD11b + macrophages play a pivotal role in vessel growth in the liver (Melgar-Lesmes and Edelman 2015), eye (Bourghardt Peebo et al. 2011;Wu et al. 2015), brain (Komohara et al. 2008), heart (Lavine et al. 2014), and several tumor models (Rivera et al. 2015). Interestingly, in a mouse liver regeneration model, infiltrating monocytes were found adjacent to proliferating capillary sprouts while resident macrophages (Kupffer cells), did not interact with vessels. Mice deficient in CD11b + monocytes showed a significant reduction in angiogenesis and liver regeneration after partial hepatectomy. The authors concluded that recruited CD11b + monocytes provided essential proliferative factors (Wnt5a and Ang-1, and the stalk cell stabilizer Notch1) for blood vessel growth (Melgar-Lesmes and Edelman 2015). Avraham-Davidi et al. (2013) confirmed this paracrine function of recruited monocytes in remodeling existing small hepatic vessels. Yet an alternative mechanism has been proposed. CD45 + CD11b + myeloid cells were shown to extravasate and form endothelium free tunnels, which over time transformed into perfused capillary sprouts in a corneal inflammation model (Bourghardt Peebo et al. 2011).
The emphasis of this study was on the CD11b + interstitial macrophage, however other leukocytes express CD11b integrin, including neutrophils. After the onset of ischemia, we saw a significant increase in the percentage of neutrophils, which was prevented by DT treatment in the CD11b DTR mice. Whether DT treatment has a direct effect on the depletion of neutrophils or a secondary effect through myeloid cells, appears to be model dependent (Dhaliwal et al. 2012;Borthwick et al. 2016 neutrophils played little role in angiogenesis in this model (McClintock and Wagner 2005). The importance of neutrophils in the process of angiogenesis in general has been less well-documented (Seignez and Phillipson 2017). In this study, coculture of systemic endothelial cells showed an enhanced proliferative phenotype only with macrophages. Neutrophils were without effect on endothelial cell proliferation. This result coupled with our previous results lead us to conclude that lung neutrophils do not play the primary role for systemic angiogenesis in this ischemia model. Because they were shown to secrete relevant cytokines, albeit at lower levels, we suggest they provide a secondary source for cytokine growth factors since CD11b + depletion with DT was more effective at blocking angiogenesis than what was shown previously with clodronate treatment. The precise mechanism whereby CD11b + leukocytes promote systemic neovascularization is not determined. We showed previously that both IL-6 and the CXC-chemokines are important for angiogenesis in this ischemia model (McClintock and Wagner 2005;S anchez et al. 2007). Examination of cytokine gene expression in CD11b + interstitial macrophages was technically difficult given the small number of cells recovered after left lung digestion and sorting. However, in vitro results demonstrated that when CD11b + cells were eliminated from the harvested pool of total lung macrophages using prior DT treatment in vivo, these macrophages secreted significantly less MIP-2a and IL-6 ( Fig. 8). Furthermore, when isolated macrophages were studied in coculture with systemic arterial endothelial cells, a substantial increase in both cytokines was measured in supernatants, perhaps contributing to increased proliferation (Fig. 9). These results are consistent with the importance of CD11b + interstitial macrophages serving a paracrine role in supporting blood vessel growth in the lung.
Two methodological issues require comment. In this study we used labeled microspheres to quantify in vivo the extent of systemic neovascularization in the lung. Histologic evaluation, commonly used in other organs, would require confirming the growth of systemic endothelial networks relative to the pulmonary vasculature and quantification of vessels based on labeling, location, and perfusion patterns. While it is conventional to label endothelium with anti-CD31, anti-CD34, or antivon Willebrand factor, both systemic and pulmonary endothelial subtypes can take up these labels equivalently as do native compared with angiogenic vessels. Furthermore, lung consolidation due to disease processes can complicate the evaluation of vessel density/unit area. Quantification based on these labels will lead to erroneous conclusions. Similar equivocal results will be obtained if these labels are used for cell sorting or quantification using flow cytometry. Consequently, in this study, we have applied the established in vivo technique using labeled microspheres (Rudolph and Heymann 1967). This approach to the quantification of systemic angiogenesis in the lung has provided a long-term, consistent, and reproducible assessment of new vessel growth to the murine lung (Mitzner et al. 2000;McClintock and Wagner 2005) and has been validated (Zhong et al. 2016).
Given the model of complete ischemia, both parenchymal and intravascular leukocytes may be important and are included in results. We have focused primarily on the changes of different leukocyte subpopulations as percentages of live cells instead of absolute numbers. We have chosen this approach since in preliminary studies, even slight interexperimental differences lead to different cell viabilities after labeling procedures of cell suspensions from dissociated lung tissue. The common technique for live cell quantification using trypan blue exclusion is typically performed prior to labeling. Hence in our hands, this approach to cell count provides an overestimation of actual cell viability, which is amplified in subsequent calculations of cell number. For these reasons we believe the leukocyte subpopulations described as percentages of live cells recovered, provide the most accurate representation of results.
In summary, we have shown that despite pulmonary artery obstruction, there was a significant increase in CD11b + interstitial macrophages in the lung D1 after the onset of ischemia. Neither recruitment nor proliferation accounted for the increase in this population of cells, suggesting in situ monocyte differentiation to the more mature interstitial macrophage. When CD11b + cells were depleted in CD11b DTR mice, angiogenesis was prevented. Secretion of IL-6 and MIP-2a from total lung macrophages was reduced when the CD11b + subpopulation was depleted. We conclude that these two proangiogenic cytokines from CD11b + leukocytes serve an essential paracrine role in ischemia-induced angiogenesis in the lung.